Showing results (1221-1230 of 1,407) with videos related to

Sort By:
Pageof 141
Pharmacology Research & Perspectives|September 23, 2020
The cerebrovascular response to norepinephrine: A scoping systematic review of the animal and human literatureLogan Froese, Joshua Dian, Alwyn Gomez, et al.
Pharmacology Research & Perspectives|September 23, 2020
Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Colombia: A systematic reviewJuan-Sebastian Franco, David Vizcaya
Pharmacology Research & Perspectives|January 9, 2020
Rituximab utilization for approved and off-label nononcology indications and patients' experiences with the Patient Alert CardKhaled Sarsour, Senam Beckley-Kartey, Simone Melega, et al.
Pharmacology Research & Perspectives|March 14, 2020
PK/PD modeling of 5-hydroxytryptophan (5-HTP) challenge test with cortisol measurement in serum and salivaZheng Guan, Gabriel Jacobs, Hans van Pelt, et al.
Pharmacology Research & Perspectives|April 3, 2020
Lipid-based gene delivery to macrophage mitochondria for atherosclerosis therapyFelix H Zakirov, Dongwei Zhang, Andrey V Grechko, et al.
Pharmacology Research & Perspectives|October 19, 2020
Poloxamer 188 Protects Isolated Adult Mouse Cardiomyocytes from Reoxygenation InjuryMichele M Salzman, Jason A Bartos, Demetris Yannopoulos, et al.
Pharmacology Research & Perspectives|September 30, 2020
Do proton pump inhibitors increase mortality? A systematic review and in-depth analysis of the evidenceMohamed Ben-Eltriki, Carolyn J Green, Malcolm Maclure, et al.
Pharmacology Research & Perspectives|April 2, 2020
Effect of the patient information brochure in communicating the risks associated with crizotinib treatment to patients with non-small cell lung cancer (NSCLC) in EuropeKui Huang, Terri Madison, Beatrice Wehler, et al.
Pharmacology Research & Perspectives|October 30, 2020
Evaluation of claims-based computable phenotypes to identify heart failure patients with preserved ejection fractionSarah S Cohen, Véronique L Roger, Susan A Weston, et al.
Pharmacology Research & Perspectives|December 6, 2020
Identification of an irreversible PPARγ antagonist with potent anticancer activityYouyi Peng, Qiang Zhang, Robert M Zielinski, et al.
Pageof 141